HSV-associated Oncolytic Virus Therapies
Aug 14, 2024
7 HSV-associated Oncolytic Virus Therapies in Late and Mid-Stage
Herpes Simplex Virus (HSV)-associated oncolytic virus therapeutics are a promising approach to cancer treatment. These treatments use genetically engineered HSV to target and destroy cancer cells while preserving healthy tissue specifically. The HSV is designed to increase selectively within tumor cells, causing th...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
